NSRX News

Latest breaking news and updates for NSRX stock.

Nasus Pharma Announces Closing of Initial Public Offering

TEL AVIV, Israel, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) (“Nasus Pharma” or the “Company”), a clinical-stage pharmaceutical company focused on the development of innovat...

What are the potential short‑term and long‑term risks (e.g., competition, reimbursement, market adoption) that could impact the stock’s performance? Are there any strategic partnerships or licensing agreements in place that could affect the company’s growth trajectory? What is the expected float percentage and daily trading volume, and how could that affect liquidity and price stability?

Ipo

10 days ago

Nasus Pharma Announces Pricing of $10 Million Initial Public Offering

TEL AVIV, Israel, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) (“Nasus Pharma” or the “Company”), a clinical-stage pharmaceutical company focused on the development of innovat...

Are there any contingent or convertible securities (e.g., warrants, options) that could further dilute existing shareholders after the IPO? What are the key regulatory milestones for Nasus Pharma’s pipeline and how might they influence the stock’s risk profile? Who are the lead underwriters and what is their track record with similar pharmaceutical offerings?

Ipo

11 days ago